Karo Healthcare AB ("Karo") has entered an exclusive licensing agreement with Moberg Pharma AB ("Moberg Pharma") regarding the commercialisation of MOB-015 in Europe. The agreement comprises 19 ...

THE Karo Platinum Project capital expenditure (capex) has risen 6,45% to US$546 million to reach production, from the previous estimate released in April, driven by higher infrastructure, engineering, ...

Karo Platinum, which is jointly owned by the government of Zimbabwe and Karo Mining Holdings. Tharisa is a 70% shareholder in Karo Mining, which, in turn, indirectly owns 85% of the Karo platinum ...

Karo Healthcare ("Karo") has appointed Konstanze Gallinatus as Chief Transformation Officer and member of the Corporate Management Team. STOCKHOLM, Sept. 30, 2025 /PRNewswire/ -- The appointment of ...

STOCKHOLM, Sept. 2, 2025 /PRNewswire/ -- Following the closing of KKR's acquisition of Karo Healthcare ("Karo") on 27 August, Karo today confirms that the agreement to acquire a portfolio of skin ...

The transaction is expected to close in the first quarter of 2026 KKR agreed to buy Karo in April Karo is a pan-European consumer healthcare company KKR-backed Karo Healthcare has agreed to buy a ...

Multiple analysts have issued price targets for $KARO recently. We have seen 3 analysts offer price targets for $KARO in the last 6 months, with a median target of ...

EXCLUSIVE: A new single-cam comedy from comedian Aaron Karo is in early development at CBS. The script for Blanks will be written by Karo, who executive produces the project alongside Wilmer ...

Private equity is known for flexibility, but the fluid tariff situation in the US has hit the market with more uncertainty than usual. One European PE firm pushing through a sale amid the turmoil is ...

KKR & Co. Inc. (NYSE:KKR) has secured a deal to acquire Swedish consumer health firm Karo Healthcare. The transaction is subject to customary regulatory conditions and approvals and is expected to ...

KKR (NYSE:KKR) agreed to acquire Karo Healthcare from a fund managed by private equity firm EQT, with the aim to accelerate the European healthcare platform's growth, the companies said on Wednesday.